Cargando…
Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer
The transcription factor (TF) SOX2 is essential for the maintenance of pluripotency and self-renewal in embryonic stem cells. In addition to its normal stem cell function, SOX2 over-expression is associated with cancer development. The ability to selectively target this and other oncogenic TFs in ce...
Autores principales: | Stolzenburg, Sabine, Rots, Marianne G., Beltran, Adriana S., Rivenbark, Ashley G., Yuan, Xinni, Qian, Haili, Strahl, Brian D., Blancafort, Pilar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413152/ https://www.ncbi.nlm.nih.gov/pubmed/22561374 http://dx.doi.org/10.1093/nar/gks360 |
Ejemplares similares
-
Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer
por: Stolzenburg, S, et al.
Publicado: (2015) -
Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor
por: Beltran, Adriana S, et al.
Publicado: (2011) -
The SOXE transcription factors—SOX8, SOX9 and SOX10—share a bi-partite transactivation mechanism
por: Haseeb, Abdul, et al.
Publicado: (2019) -
Bidirectional modulation of endogenous EpCAM expression to unravel its function in ovarian cancer
por: van der Gun, B T F, et al.
Publicado: (2013) -
Transcriptional regulation of chondrogenesis by coactivator Tip60 via chromatin association with Sox9 and Sox5
por: Hattori, Takako, et al.
Publicado: (2008)